hydroxychloroquine has been researched along with Granulomatosis, Orofacial in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case report discusses orofacial granulomatosis, a condition that often poses diagnostic and management challenges." | 1.72 | Orofacial Granulomatosis Treated With Combination of Intralesional Steroids and Hydroxychloroquine. ( Alawai, F; Bindakhil, MA; Sollecito, TP; Stoopler, ET, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bindakhil, MA | 1 |
| Stoopler, ET | 1 |
| Alawai, F | 1 |
| Sollecito, TP | 1 |
| Yan, C | 1 |
| Shang, Q | 1 |
| Geng, S | 1 |
2 other studies available for hydroxychloroquine and Granulomatosis, Orofacial
| Article | Year |
|---|---|
Orofacial Granulomatosis Treated With Combination of Intralesional Steroids and Hydroxychloroquine.
Topics: Adult; Female; Granulomatosis, Orofacial; Humans; Hydroxychloroquine; Injections, Intralesional; Ste | 2022 |
Hydroxychloroquine-induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN mutation.
Topics: Acute Generalized Exanthematous Pustulosis; Granulomatosis, Orofacial; Homozygote; Humans; Hydroxych | 2022 |